Proteomics: Current State and Future Directions

The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a  |  more...

Presbyopia Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Presbyopia Global Clinical Trials Review, H1, 2012 provides data on the Presbyopia clinical trial scenario. This report provides elemental information and data relating to the  |  more...

Metastatic Hepatocellular Carcinoma (HCC) – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2012', provides an overview of the Metastatic Hepatocellular Carcinoma (HCC) therapeutic pipeline. This report provides information  |  more...

This triple analysis focuses on cancer drug development strategies by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors and by the compound strategy of Antibodies. Each of these three individual parts is evaluated  |  more...

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Breast Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Antibodies). Each of these three individual parts is  |  more...